As part of the ADAPT SMART Work Package 3, the D3.04 workstream was tasked to analyse the specific views and uncertainties of stakeholders facing MAPPs, and identify enablers to manage and reduce them.
About adaptsmart-adminThis author has not yet filled in any details.
So far adaptsmart-admin has created 75 blog entries.
Enablers of decision making in an adaptive environment: managing uncertainties and disengagement (D3.03)
This report identified that the terminology surrounding disengagement from MAPPs needs further clarification as interchangeable terminology such as, ‘exit strategy’, ‘withdrawal’, or ‘disinvestment’ holds different meanings and different implications to different stakeholders.
Managed Entry Agreements for Pharmaceuticals in the Context of Adaptive Pathways in Europe (D3.05 & D3.07)
This review reports the findings of activities undertaken by the ADAPT-SMART consortium to identify enablers and explore the suitability of managed entry agreements for adaptive pathways products in Europe.
Work package 1 has focused on evidence generation (in a MAPPs context) throughout the product life-cycle. Earlier work has reviewed IMI and non-IMI projects that might further support different stakeholders in developing and/or implementing the MAPPs approach.
On March 21st and 22nd, ADAPT SMART held its closing meeting at the Hungarian Academy of Sciences in Budapest, highlighting the programme’s achievements and next steps for delivery after the project’s conclusion.
Moving MAPPs into Practice through ADAPT SMART’s Legacy – interview with Hans-Georg Eichler and Solange Rohou
Moving MAPPs into Practice through ADAPT SMART’s Legacy Now that the ADAPT SMART project is coming to a close, one of the project’s goals was to develop the frameworks and knowledge base that could put MAPPs into practice in Europe. In an interview with Hans-Georg Eichler and Solange Corriol-Rohou, the sustainability approach of [...]
How will the normal timelines be impacted by MAPPs given there is no hard starting point? – interview with Stuart Faulkner
How will the normal timelines be impacted by MAPPs given there is no hard starting point? The Centre for the Advancement of Sustainable Medical Innovation (CASMI) is one of the world’s thought leaders in the theory and implementation of adaptive pathways and a very active partner in the ADAPT SMART project. Stuart Faulkner [...]
Has ADAPT SMART been successful in changing the way we think about approving new therapies? – interview with Ad Schuurman
Has ADAPT SMART been successful in changing the way we think about approving new therapies? Ad Schuurman sits at the confluence of three key circles in European healthcare. His principal day job is at the National Health Care Institute of the Netherlands (Zorginstituut Nederland), but he is currently seconded to the EMA, and [...]
Have Stakeholders Been More Involved at the Centre of Decision Making? – interview with Yann Le Cam and Mathieu Boudes
Have Stakeholders Been More Involved at the Centre of Decision Making? Yann Le Cam from Eurordis and Mathieu Boudes from the European Patients’ Forum, two of Europe’s leading patient representatives participating in ADAPT SMART, discussed adaptive pathways from the patient perspective. EURORDIS is a non-governmental patient-driven alliance of patient organisations representing 792 rare disease [...]
Evidence Generation Throughout the Life Cycle The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care in England. NICE co-leads work package 1 of ADAPT SMART on ‘evidence generation throughout the product life-cycle’ and has contributed to the work on the suitability of [...]